MiMedx Group (NASDAQ:MDXG) Stock Rating Reaffirmed by HC Wai

HC Wainwright reissued their buy rating on shares of MiMedx Group (NASDAQ:MDXG – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $11.00 price objective on the stock. HC Wainwright also issued estimates for MiMedx Group’s Q2 2024 earnings at $0.10 EPS, Q3 2024 earnings at $0.10 EPS, […]

Related Keywords

Dekabank Deutsche Girozentrale , Riccis Whitlow , Mt Bank Corp , E Fund Management Co , News Ratings For Mimedx Group Daily , Securities Exchange Commission , Mimedx Group Inc , Mimedx Group Stock Performance , Institutional Trading Of Mimedx Group , Mimedx Group , Free Report , Street Capital , Medx Group , Get Free Report , Frank Iv Hulse , Exchange Commission , Bank Deutsche Girozentrale , Mimedx Group Daily , Nasdaq Mdxg , Mdxg , Medical , Reiterated Rating , Hc Wainwright ,